Drug Discovery Through Precision Design
Discovering novel drugs and bringing them to patients is increasingly important but remains a technological and scientific challenge. At Aspaldiko Therapeutics, we focus on revolutionising the design of the single most important class of medication: enzyme inhibitors! Through our unique physics-based computational platform, we remove uncertainty and human bias from the early stages of drug design. By avoiding costly cycles of design, synthesis, and testing in biological systems, we significantly increase the efficiency of developing new drugs. We seek to optimize our impact through internal drug development, strategic partnerships, and a software licensing approach! Right now, Aspaldiko Therapeutics is pursuing seed funding to experimentally verify our computational platform by discovering lead compounds for high-value enzyme targets. Contact me below to join the future of the pharmaceutical sector!